Template:Map/Ether phospholipid: Difference between revisions
(New page: =Ether Phospholipid Biosynthesis= {| |- |style="text-align:center;"|dihydroxy acetone p {{Map/ReactionDown|R1-CO-CoA|CoA|[http://metabolomics.jp/wiki/Enzyme:2.3.1.42 2.3.1.42]}} |{{Map/Re...) |
mNo edit summary |
||
| Line 13: | Line 13: | ||
|style="text-align:center;"|1-acyl ''sn''-glycerol 3p | |style="text-align:center;"|1-acyl ''sn''-glycerol 3p | ||
|- | |- | ||
|{{Map/ReactionDown35|R1-OH|<small>→R-COOH</small>|}}1-alkyl dihydroxy acetone p{{Map/ReactionDown35|NADPH|<small>→NADP+</small>|}} | |{{Map/ReactionDown35|R1-OH|<small>→R-COOH</small>|}}1-alkyl dihydroxy acetone p<ref>アルキル型を含むエーテルリン脂質はペルオキシソームで合成。ペルオキシソームを欠乏するZellweger症候群では血小板活性化因子PAFが著しく減少。</ref>{{Map/ReactionDown35|NADPH|<small>→NADP+</small>|}} | ||
| | | | ||
|style="text-align:center;"|[[Image:Arrow00d.png]] | |style="text-align:center;"|[[Image:Arrow00d.png]] | ||
| Line 31: | Line 31: | ||
|1-alkyl 2-acyl ''sn''-glycerol<br/> | |1-alkyl 2-acyl ''sn''-glycerol<br/> | ||
{{Map/ReactionDown35|CDP-choline|}} | {{Map/ReactionDown35|CDP-choline|}} | ||
platelet-activating factor (PAF; 2=acetyl)<br/>or plasmalogen | platelet-activating factor (PAF; 2=acetyl)<br/>or plasmalogen<ref>プラスマローゲン（不飽和エーテルリン脂質）は飽和エーテルリン脂質の脱水素で生成。</ref> | ||
| | | | ||
|1,2-diacyl ''sn''-glycerol<br/> | |1,2-diacyl ''sn''-glycerol<br/> | ||
Revision as of 15:10, 2 July 2009
Ether Phospholipid Biosynthesis
dihydroxy acetone p
|
1.1.1.8 NADH NAD+ |
sn-glycerol 3p
| ||||||||||
| 1-acyl dihydroxy acetone p | 1.1.1.8 NADH NAD+ |
1-acyl sn-glycerol 3p | ||||||||||
|
| |||||||||||
1-alkyl sn-glycerol 3p
|
1-acyl sn-glycerol 3p
| |||||||||||
1-alkyl 2-acyl sn-glycerol 3p
|
1-acyl 2-acyl sn-glycerol 3p
| |||||||||||
1-alkyl 2-acyl sn-glycerol
platelet-activating factor (PAF; 2=acetyl) |
1,2-diacyl sn-glycerol |
